SHOCKING: Ovarian cancer | Mind Blowing Facts

Blood RNA Marker Flagged a Hidden Ovarian Cancer Precursor That Scans and CA125 Tests Miss in Stored Samples

Researchers identified a blood-based RNA marker that detected STIC, a precursor to high-grade serous ovarian cancer, but the experimental test requires prospective trials and is not available clinically.

Medical Daily · 17h ago

Delhi HC grants 7-day custody parole to Al Falah University chairman to tend to ailing wife

The Delhi High Court has granted a seven-day custody parole to Jawad Ahmed Siddiqui, chairman of Al Falah University, who sought interim bail due to his wife's critical Stage-4 ovarian cancer. However, the Enforcement Directorate has raised objections, citing serious allegations of money laundering and previous involvement in a terror…

The Economic Times · Nov 6

7 Breast Changes That Could Signal Early Breast Cancer

A small lump, an unusual change in breast shape or even a slight difference in the nipple may seem harmless. Many women ignore these changes because they do not experience pain or feel otherwise unwell. But breast cancer does not always announce itself through obvious symptoms. Sometimes, the earliest warning…

MyLifeXP · Oct 30

Why Tumour Marker Tests Sold to Healthy People Create False Alarms

A blood test that promises to detect cancer early sounds like exactly the kind of thing a cautious person should do. Increasingly, diagnostic labs across India are bundling tests for CA-125, PSA, CEA, AFP, and CA 19-9 into routine health packages marketed to people who feel perfectly well. The logic…

Times Life · Oct 24

Ovaries Keep Remodeling for Decades After Menopause, and Tissue From Women 70 and Older Showed More Inflammation

A Northwestern and Buck Institute study of 28 women found that the ovary keeps changing for decades after menopause, with more inflammation in older tissue.

Medical Daily · Oct 15

Estimated 48% of Women with Heavily Treated Ovarian Cancer Were Alive at Three Years in Small Immunotherapy Trial

An early trial of botensilimab plus balstilimab showed an estimated 48% three-year survival rate in recurrent ovarian cancer. Here is what the data mean.

Medical Daily · Oct 7

In 2023, New York mother arranged a fundraiser to erase strangers' medical bills after her death

Casey McIntyre's battle with stage four ovarian cancer led her to launch a remarkable campaign aimed at eliminating medical debt. Through her organization, Undue Medical Debt, she managed to relieve over $120 million in healthcare bills, directly benefiting more than 51,000 people. Her initiative stirred local community movements focused on…

The Times of India · Sep 30

Can removing your fallopian tubes really reduce your risk of ovarian cancer?

Ovarian cancer has a particularly poor survival rate. Only one in two women will live five years beyond their diagnosis.

The Conversation · Sep 7

Survival Gaps in Ovarian Cancer Track with Neighborhood Conditions, Pointing Toward Treatment Access

Women with ovarian cancer in highly vulnerable neighborhoods faced 20% higher mortality in a new study. Researchers point toward care access.

Medical Daily · Aug 12

Cancer Cells That Survived Chemo Released a Common Sugar, and Their Neighbors Started Letting G

Wistar researchers found that fructose acts as a message between ovarian cancer cells, stripping the cholesterol that holds tumors together.

Medical Daily · Aug 12